Treatment of patients (pts) with chronic myeloid leukemia (CML) and imatinib failure after developing Bcr-Abl kinase mutations with allogeneic stem cell transplantation (ASCT)

被引：0
|
作者：
Jabbour, E [1 ]
Cortes, J [1 ]
De Lima, M [1 ]
Andersson, B [1 ]
Giralt, S [1 ]
Kantarjian, H [1 ]
Champlin, R [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2006年 / 12卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2005.11.058
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
43
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [21] Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia
    Mario Tiribelli
    Roberto Latagliata
    Luigiana Luciano
    Fausto Castagnetti
    Antonella Gozzini
    Giovanna Rege Cambrin
    Mario Annunziata
    Fabio Stagno
    Patrizia Pregno
    Francesco Albano
    Elisabetta Abruzzese
    Pellegrino Musto
    Enrico Montefusco
    Carmen Fava
    Renato Fanin
    Fabrizio Pane
    Gianantonio Rosti
    Massimo Breccia
    Giuliana Alimena
    Paolo Vigneri
    Annals of Hematology, 2013, 92 : 179 - 183
  • [22] Allogeneic Stem Cell Transplantation for Patients with T315I BCR-ABL Mutated Chronic Myeloid Leukemia
    Xu, Lan-Ping
    Xu, Zheng-Li
    Zhang, Xiao-Hui
    Chen, Huan
    Chen, Yu-Hong
    Han, Wei
    Chen, Yao
    Wang, Feng-Rong
    Wang, Jing-Zhi
    Wang, Yu
    Yan, Chen-Hua
    Mo, Xiao-Dong
    Liu, Kai-Yan
    Huang, Xiao-Jun
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (06) : 1080 - 1086
  • [23] Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia
    Tiribelli, Mario
    Latagliata, Roberto
    Luciano, Luigiana
    Castagnetti, Fausto
    Gozzini, Antonella
    Cambrin, Giovanna Rege
    Annunziata, Mario
    Stagno, Fabio
    Pregno, Patrizia
    Albano, Francesco
    Abruzzese, Elisabetta
    Musto, Pellegrino
    Montefusco, Enrico
    Fava, Carmen
    Fanin, Renato
    Pane, Fabrizio
    Rosti, Gianantonio
    Breccia, Massimo
    Alimena, Giuliana
    Vigneri, Paolo
    ANNALS OF HEMATOLOGY, 2013, 92 (02) : 179 - 183
  • [24] In patients with chronic myelogeneous leukemia (CML), response dynamics to nilotinibafter imatinib failure depend on thetype of BCR-ABL mutations
    Soverini, S.
    Saglio, G.
    Branford, S.
    Radich, J.
    Kim, D. W.
    Hughes, T.
    Mueller, M.
    Erben, P.
    Hochhaus, A.
    Shou, Y.
    Weitzman, A.
    Baccarani, M.
    Martinelli, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 320 - 320
  • [25] Impact of BCR-ABL mutations on patients with chronic myeloid leukemia
    Hochhaus, Andreas
    La Rosee, Paul
    Mueller, Martin C.
    Ernst, Thomas
    Cross, Nicholas C. P.
    CELL CYCLE, 2011, 10 (02) : 250 - 260
  • [26] Dynamics of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia (CML) after treatment with one, two or three tyrosine kinase inhibitors (TKI).
    Jabbour, Elias
    Jones, Dan
    Kantarjian, Hagop
    O'Brien, Susan
    Garcia-Manero, Guillermo
    Giles, Francis
    Wierda, William
    Cortes, Jorge
    BLOOD, 2006, 108 (11) : 225A - 225A
  • [27] Spectrum of BCR-ABL mutations in Azerbaijanian imatinib-resistant patients with chronic myeloid leukemia
    Hasanova, Aypara
    Asadov, Chingiz
    Karimova, Nigar
    Shirinova, Aytan
    Aliyeva, Gunay
    Alimirzoyeva, Zohra
    PATHOLOGY & ONCOLOGY RESEARCH, 2023, 29
  • [28] Clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate
    Nicolini, Franck
    HEMATOLOGIE, 2006, 12 (06): : 373 - 374
  • [29] Spectrum of BCR-ABL Mutations and Treatment Outcomes in Ethiopian Imatinib-Resistant Patients With Chronic Myeloid Leukemia
    Tadesse, Fisihatsion
    Asres, Getahun
    Abubeker, Abdulaziz
    Gebremedhin, Amha
    Radich, Jerald
    JCO GLOBAL ONCOLOGY, 2021, 7 : 1187 - 1193
  • [30] Nilotinib Lowers the Incidence of BCR-ABL Mutations and Improves the Molecular Response Kinetics Compared with Imatinib in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia (CML)
    Hochhaus, Andreas
    Saglio, Giuseppe
    Larson, Richard A.
    Kim, Dong-Wook
    Flinn, Ian W.
    Goh, Yeow-Tee
    Dorlhiac-Llacer, Pedro Enrique
    Porkka, Kimmo
    Kurokawa, Mineo
    DeSouza, Carmino
    Shou, Yaping
    Gallagher, Neil J.
    Haque, Ariful
    Kantarjian, Hagop
    Hughes, Timothy P.
    BLOOD, 2010, 116 (21) : 1406 - 1407
12345